Learn More
The RENAAL Study is a double-blind, placebo-controlled trial to evaluate the renal protective effects of losartan in Type 2 diabetic patients with nephropathy. The study has enrolled 1513 patients(More)
OBJECTIVE To evaluate the efficacy and safety of gaboxadol in the treatment of Primary Insomnia. METHODS Two studies were performed in patients 18 to 65 years of age with Primary Insomnia. After a(More)
This study investigated the anti-hypertensive efficacy and tolerability of once-daily losartan potassium (50 mg titrated to 100 mg), an angiotensin II receptor antagonist, compared with once daily(More)